7月30日，BrightSpring Health Services盘中上涨5.07%，报72.885美元/股，成交额8419.06万美元。
消息面上，公司将于7月31日盘前发布第二季度财报，市场预期本季度营收36.58亿美元，同比增长22.34%，调整后每股收益0.40美元，同比增长132.20%。7月以来，多家投行密集上调目标价：UBS由63美元上调至85美元，Morgan Stanley由71美元上调至80美元，Guggenheim以81美元目标价首次覆盖给予买入评级，Raymond James以80美元目标价首次覆盖给予跑赢大市评级。此前一季度公司业绩大幅超预期，调整后EPS为0.39美元，超预期25.81%，营收36.14亿美元亦超出市场预期。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.